Proliferator-activated receptor gamma agonist rosiglitazone effect on extravillous cytotrophoblasts in vitro - - GEO DataSets - NCBI

Warning: The NCBI web site requires JavaScript to function. more...

Result Filters

Summary

Format

Summary
Summary (text)
Unique Identifier List

Send to:

Choose Destination

File
Clipboard
Collections

Links from GEO Profiles

Full record GDS4875

Proliferator-activated receptor gamma agonist rosiglitazone effect on extravillous cytotrophoblasts in vitro

Analysis of EVCTs isolated from first trimester placenta and treated with rosiglitazone, a PPARγ agonist. EVCT invasion into the uterus is critical for placental and fetal development. Results provide insight into the molecular basis of PPARγ-mediated regulation of EVCT invasion in vitro.

Organism:: Homo sapiens

Type:: Expression profiling by array, count, 2 agent sets

Platform:: GPL571
Series:: GSE28426
10 Samples

Download data: CEL

DataSet

Accession:: GDS4875

ID:: 4875

PubMed Full text in PMC Similar studies GEO Profiles Analyze DataSet

Supplemental Content

Related information

PubMed
Related PubMed entries
Full text in PMC
PMC links
Similar studies
Similar studies
GEO Profiles
Related GEO
BioProject
BioProject links
GEO DataSets
Related GEO DataSets
Taxonomy
Taxonomy

Important Links

Recent activity

Clear Turn Off Turn On

Proliferator-activated receptor gamma agonist rosiglitazone effect on extravillo...
Proliferator-activated receptor gamma agonist rosiglitazone effect on extravillous cytotrophoblasts in vitro
Accession: GDS4875

GEO DataSets
Related DataSets for GEO Profiles (Select 113321982) (1)
GEO DataSets

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

You are here: NCBI > Genes & Expression > Gene Expression Omnibus (GEO) Datasets